Coasterchase program - 24 months
Active Cooperative Agreement Awarded Last action
- Award ID
- HR0011262E007
- Recipient
-
Carnegie-Mellon University UEI U3NKNFLNQ613
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $4,428,373
Award facts
- Assistance listing
- 12.910 Research and Technology Development
- Completion date 40% complete
- Place of performance
- Pittsburgh, PA 15213, USA
Award details come from USAspending.gov.
About this award
The Defense Advanced Research Projects Agency awarded Carnegie Mellon University a $4.428 million Cooperative Agreement on January 1, 2026, under DARPA's Research and Technology Development program (CFDA 12.910) to support research and advanced technology development with potential military or dual-use application through December 31, 2027.
The award funds the COASTERCHASE program over 24 months, with work performed at Carnegie Mellon's Pittsburgh, Pennsylvania campus. The research program is structured as a cooperative agreement in which Carnegie Mellon serves as the prime recipient with sub-recipient pass-through to multiple research collaborators. The University of Pittsburgh, Edulis Therapeutics Inc., and Mayo Clinic each received sub-awards under the cooperative agreement to conduct research on "GutHarmony: Origami-Inspired Ingestible Platform for Precision Closed-Loop Enteric Neuromodulation," awarded between June 30 and July 27, 2026. Additionally, Mayo Clinic received a separate sub-award dated February 19, 2026, for work on "RECTIFY: Rechargeability Enabled by Coated Interfaces and Differentiable Physical Modeling."
The Research and Technology Development program supports basic, applied, and advanced research at educational institutions, nonprofit organizations, and commercial firms, with awards based on competitive scientific and technical merit review, relevance to DARPA's mission, institutional capability, technology transition planning, and cost realism.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $2,181,467 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $604,906 | |
| Amendment | $0 | |
| Amendment | $900,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $742,000 |
Show all 11
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $40,100 | |
| Edulis Therapeutics Inc. | $68,917 | |
| Mayo Clinic | $119,136 | |
| Mayo Clinic | $252,018 |
Quick answers
Who received award HR0011262E007?
HR0011262E007 was awarded to Carnegie-Mellon University by Defense Advanced Research Projects Agency (Department of Defense) on January 1, 2026.
How much is award HR0011262E007 worth?
$4,428,373 has been obligated on HR0011262E007.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award